{"id":"44514d3144ce","type":"article","url":"https://hartvaat.nl/2024/06/11/remote-beoordeling-na-acs-gerandomiseerde-trial/","title":"Remote beoordeling na ACS: gerandomiseerde trial","title_en":"Randomized Trial of Remote Assessment of Patients After an Acute Coronary Syndrome.","category":"preventie","category_label":"Preventie","professions":["cardioloog","huisarts"],"tags":[],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2024.03.398","source_url":"https://doi.org/10.1016/j.jacc.2024.03.398","authors":["Nasser S Alshahrani","Adam Hartley","James Howard","Reza Hajhosseiny","Saud Khawaja","Henry Seligman","Tamim Akbari","Badr A Alharbi","Paul Bassett","Rasha Al-Lamee","Darrel Francis","Amit Kaura","Mihir A Kelshiker","Nicholas S Peters","Ramzi Khamis"],"significance":6,"published":"2024-06-11","source_date":"2024-06-11","image":"","kennis":[],"congress":"","summary_en":"This randomized trial demonstrated that remote follow-up after ACS is as safe as conventional clinic visits, supporting telecardiology as a viable model for post-acute coronary care delivery.","created":"2026-07-03T10:30:59Z","updated":"2026-07-03T13:30:02Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Gerandomiseerde trial toonde dat remote follow-up na ACS even veilig is als conventionele poliklinische controles. Telecardiologie vermindert reistijd en kosten zonder de klinische veiligheid in gevaar te brengen.","abstract_original":"BACKGROUND: Telemedicine programs can provide remote diagnostic information to aid clinical decisions that could optimize care and reduce unplanned readmissions post-acute coronary syndrome (ACS). OBJECTIVES: TELE-ACS (Remote Acute Assessment of Patients With High Cardiovascular Risk Post-Acute Coronary Syndrome) is a randomized controlled trial that aims to compare a telemedicine-based approach vs standard care in patients following ACS. METHODS: Patients were suitable for inclusion with at least 1 cardiovascular risk factor and presenting with ACS and were randomized (1:1) before discharge. The primary outcome was time to first readmission at 6 months. Secondary outcomes included emergency department (ED) visits, major adverse cardiovascular events, and patient-reported symptoms. The primary analysis was performed according to intention to treat. RESULTS: A total of 337 patients were randomized from January 2022 to April 2023, with a 3.6% drop-out rate. The mean age was 58.1 years. There was a reduced rate of readmission over 6 months (HR: 0.24; 95% CI: 0.13-0.44; P < 0.001) and ED attendance (HR: 0.59; 95% CI: 0.40-0.89) in the telemedicine arm, and fewer unplanned coronary revascularizations (3% in telemedicine arm vs 9% in standard therapy arm). The occurrence of chest pain (9% vs 24%), breathlessness (21% vs 39%), and dizziness (6% vs 18%) at 6 months was lower in the telemedicine group. CONCLUSIONS: The TELE-ACS study has shown that a telemedicine-based approach for the management of patients following ACS was associated with a reduction in hospital readmission, ED visits, unplanned coronary revascularization, and patient-reported symptoms. (Telemedicine in High-Risk Cardiovascular Patients Post-ACS [TELE-ACS]; NCT05015634)."}